Literature DB >> 17692566

Evidence for cost reduction based on pre-admission MRSA screening in general surgery.

Ricarda Diller1, Anne K Sonntag, Alexander Mellmann, Knut Grevener, Norbert Senninger, Frank Kipp, Alexander W Friedrich.   

Abstract

Colonization with methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for MRSA infection causing increased costs in patient's care and treatment. To evaluate cost efficiency, pre-admission MRSA screening and subsequent MRSA decolonization of patients admitted to the Department of General Surgery at the University Hospital of Münster were determined. In 2004, 2054 (89.3%) out of the total of 2299 hospital-admitted patients were screened for MRSA (1769 elective and 530 direct admissions); 1536 patients underwent pre-admission MRSA screening (86.8% of the 1769 elective admissions), of whom seven patients (0.5%) were MRSA-positive and five of these were successfully decolonized before admission. In case of direct admissions, i.e., emergency cases or transferral from other hospitals, 2.4% and 8.6% were MRSA-positive, respectively. There were 25 patients MRSA positive during their hospital stay, two of these were nosocomially acquired, which represent 0.1 nosocomial MRSA cases in 1000 in-patients. The average MRSA carrier was (65+/-15 years) older than the other patients (55+/-17 years), had a significantly higher rate of pulmonary disease, coronary heart disease and certain infections; and had a longer hospital stay (27 versus 10 days, p<0.05). The total costs of the MRSA screening were approximately 20,000 euro. Since the estimated costs for handling MRSA treatment and isolation during a hospital stay are 6000-10,000 euro for each affected patient, we estimated that approximately 20,000 euro could be saved by detecting and successfully decolonizing a total of five patients through pre-admission screening. In this calculation, additional costs due to the increased morbidity and mortality of MRSA carriers and the possible spread of MRSA through unrecognized colonization were not included. In conclusion, pre-admission screening for MRSA is an effective method to reduce the hospital burden of MRSA-colonized patients and the savings due to consistent decolonization before elective admission outweigh the costs of screening.

Entities:  

Mesh:

Year:  2007        PMID: 17692566     DOI: 10.1016/j.ijheh.2007.06.001

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  19 in total

Review 1.  Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany.

Authors:  A Tübbicke; C Hübner; A Kramer; N-O Hübner; S Fleßa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-10       Impact factor: 3.267

Review 2.  Immunopathogenesis of Staphylococcus aureus pulmonary infection.

Authors:  Dane Parker; Alice Prince
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

3.  MRSA screening in the vascular day-case population.

Authors:  Y Ahmad; S Khandelwal; A M Nicolson; M H Simms
Journal:  Ann R Coll Surg Engl       Date:  2010-09-22       Impact factor: 1.891

Review 4.  Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.

Authors:  Fernando Antonanzas; Carmen Lozano; Carmen Torres
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

5.  Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 - current considerations by the DGKH Management Board.

Authors:  Arne Simon; Martin Exner; Axel Kramer; Steffen Engelhart
Journal:  GMS Krankenhhyg Interdiszip       Date:  2009-04-09

6.  MRSA in a large German University Hospital: Male gender is a significant risk factor for MRSA acquisition.

Authors:  Markus Kupfer; Lutz Jatzwauk; Stephan Monecke; Jana Möbius; Axel Weusten
Journal:  GMS Krankenhhyg Interdiszip       Date:  2010-09-21

7.  Can the Hazard Assessment and Critical Control Points (HACCP) system be used to design process-based hygiene concepts?

Authors:  N-O Hübner; S Fleßa; J Haak; F Wilke; C Hübner; C Dahms; W Hoffmann; A Kramer
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15

8.  HIC@RE … and its relevance for a company like RIEMSER.

Authors:  Berno Müller; Jürgen Becker
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15

9.  Cost comparison of MRSA screening and management - a decision tree analysis.

Authors:  Andrea Tübbicke; Claudia Hübner; Nils-Olaf Hübner; Christian Wegner; Axel Kramer; Steffen Fleßa
Journal:  BMC Health Serv Res       Date:  2012-12-01       Impact factor: 2.655

10.  Prevalence dependent calibration of a predictive model for nasal carriage of methicillin-resistant Staphylococcus aureus.

Authors:  Johannes Elias; Peter U Heuschmann; Corinna Schmitt; Frithjof Eckhardt; Hartmut Boehm; Sebastian Maier; Annette Kolb-Mäurer; Hubertus Riedmiller; Wolfgang Müllges; Christoph Weisser; Christian Wunder; Matthias Frosch; Ulrich Vogel
Journal:  BMC Infect Dis       Date:  2013-02-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.